← Open Payments lookup

MELISSA PENNINGTON: Open Payments

NPI 1225149685 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$354 in 17 payments from 12 companies in 2025. Trend: 2023 $151 · 2024 $200 · 2025 $354

Food & beverage: $354
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation3$82
ABBVIE INC.3$73
Otsuka America Pharmaceutical, Inc.2$32
AstraZeneca Pharmaceuticals LP1$24
Aimmune Therapeutics, Inc.1$23
Eisai Inc.1$21
Sumitomo Pharma America, Inc.1$20
Bayer Healthcare Pharmaceuticals Inc.1$19
Axsome Therapeutics, Inc.1$16
Corcept Therapeutics1$15

Products named: LEQVIO, REXULTI, LINZESS, QULIPTA, FARXIGA, VOWST, Leqembi, GEMTESA.

Industry payments across MO — which companies pay providers there.